首页 › 非小细胞肺癌 › 加利福尼亚州 › Mountain View
Mountain View CA 非小细胞肺癌临床试验
21项针对 非小细胞肺癌的研究正在 Mountain View及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
招募中1/2 期
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 距离 5 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 距离 5 英里
- Stanford Cancer Institute Palo Alto, Palo Alto · 距离 5 英里
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
招募中3 期
- Stanford University, Stanford · 距离 5 英里
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
招募中2 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
招募中观察性研究
- Stanford University, Palo Alto · 距离 5 英里
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
招募中2 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
- Stanford Hospital and Clinics, Stanford · 距离 5 英里
- Stanford Hospital Investigational Drug Services, Stanford · 距离 5 英里
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- Stanford Cancer Center, Palo Alto · 距离 5 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
招募中1/2 期
- Stanford University Medical Center - Neurology, Stanford · 距离 5 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Palo Alto Medical Foundation Research Center, Palo Alto · 距离 5 英里
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
招募中1/2 期
- Stanford University Medical Center, Stanford · 距离 5 英里
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
招募中1 期
- Stanford University Medical Center, Palo Alto · 距离 5 英里
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
招募中1 期
- Stanford University, Palo Alto · 距离 5 英里
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- Stanford University - Stanford Cancer Institute, Stanford · 距离 5 英里
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- Stanford Medicine Cancer Center, Stanford · 距离 5 英里
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- Stanford University, Stanford · 距离 5 英里
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
招募中1/2 期
- Stanford Women's Cancer Center, Palo Alto · 距离 5 英里
Engagement of Veterans With Lung Cancer
招募中
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 距离 5 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Stanford · 距离 5 英里
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
招募中1 期
- Stanford University, Stanford · 距离 5 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Mountain View的其他研究
- 癌症（所有类型）40 项研究
- 乳腺癌26 项研究
- 转移性癌症25 项研究
- 急性髓系白血病19 项研究
- 卵巢癌19 项研究
- 自闭症谱系障碍17 项研究
- 肺癌17 项研究
- 前列腺癌15 项研究
- 心力衰竭15 项研究
- 自闭症13 项研究
- 急性淋巴细胞白血病13 项研究
- 结直肠癌13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。